Intrinsic Value of S&P & Nasdaq Contact Us

Harpoon Therapeutics, Inc. HARP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$700.00
+2942.2%

Harpoon Therapeutics, Inc. (HARP) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 7 Buy, 2 Hold.

The consensus price target is $700.00, representing an upside of 2942.2% from the current price $23.01.

HARP Stock — 12-Month Price Forecast

$700.00
▲ +2,942.16% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Harpoon Therapeutics, Inc., the price target is $700.00.
The average price target represents a +2,942.16% change from the last price of $23.01.

HARP Analyst Ratings

Buy
9
Ratings
7 Buy
2 Hold
Based on 9 analysts giving stock ratings to Harpoon Therapeutics, Inc. in the past 3 months
Rating breakdown
Buy
7 78%
Hold
2 22%
78%
Buy
7 analysts
22%
Hold
2 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message